Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled time : 13:15 save search
F-star Therapeutics to Present at The Society for Immunotherapy of Cancer (SITC) 2021 Conference
Published: 2021-11-12 (Crawled : 13:15) - globenewswire.com
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: -2.48%
H: 0.0%
C: 0.0%
immunotherapy therapy cancer conference
Cellectis Presents First Preclinical Data on UCARTMESO, an Allogeneic CAR-T Cell Product Candidate Targeting Mesothelin to Treat Solid Tumors at the Annual Meeting of the Society for Immunotherapy of Cancer
Published: 2021-11-12 (Crawled : 13:15) - globenewswire.com
CLLS | $2.47 0.4% 12K
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
immunotherapy solid tumors therapy car-t cancer ucartmeso preclinical t-cell pre-clinical
Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-10 (Crawled : 13:15) - biospace.com/
TSHA | $2.265 -6.02% -6.4% 1.8M
|
Health Technology
|
| O: 0.66%
H: 6.0%
C: 3.76%
financial results gene therapies results therapy gene therapy
Poseida Therapeutics to Present Preclinical Data Highlighting Fully Allogeneic CAR-T Product Candidates at the Society for Immunotherapy of Cancer 2021 Annual Meeting
Published: 2021-11-09 (Crawled : 13:15) - prnewswire.com
PSTX | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: -1.96%
H: 0.0%
C: 0.0%
immunotherapy therapy car-t cancer preclinical pre-clinical
ATI Physical Therapy Expands to Growing Houston Market with Acquisition of Hope Rehab Katy in Katy, TX
Published: 2021-11-08 (Crawled : 13:15) - prnewswire.com
ATIP 4 | $4.16 1.46% -3.85% 3K
|
Manufacturing
|
| O: 5.28%
H: 0.0%
C: -3.45%
acquisition therapy growing
Selecta Biosciences Announces Top Line Data from the Phase I SEL-399 AAV Empty Capsid Study, Highlighting Potential Benefits of ImmTOR™ in Gene Therapy
Published: 2021-11-08 (Crawled : 13:15) - globenewswire.com
SELB 4 | $0.8812 -8.0% 2.12% 0
|
Health Technology
|
| O: 9.25%
H: 2.23%
C: -6.82%
potential gene therapy therapy topline
Selecta Biosciences and Genovis Enter Exclusive License Agreement to Advance Next-Generation IgG Protease in Gene Therapy and Autoimmune Disease
Published: 2021-10-21 (Crawled : 13:15) - biospace.com/
SELB 4 | $0.8812 -8.0% 2.12% 0
|
Health Technology
|
| O: 0.0%
H: 4.37%
C: 1.54%
disease gene therapy therapy license
Clinical Data from Editas Medicine’s Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10 to be Presented at the European Society of Gene and Cell Therapy Annual Congress
Published: 2021-10-20 (Crawled : 13:15) - globenewswire.com
EDIT | $5.5 -0.9% -0.91% 2.3M
|
Health Technology
|
| O: 0.64%
H: 0.71%
C: -2.76%
europe ongoing phase 1 therapy trial
Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasibility of simultaneous psilocybin administration in small groups
Published: 2021-10-20 (Crawled : 13:15) - globenewswire.com
CMPS | $8.35 -0.83% -0.84% 370K
|
Health Technology
|
| O: 2.13%
H: 2.17%
C: 0.7%
therapy cancer depression comp360 psilocybin
Home Rehabilitation Products & Services Market to Advance at CAGR of 6.8%; Growing Clinical Effectiveness of Products in Orthopedic Patients Enriches Home-based Physiotherapy Programs: TMR Study
Published: 2021-10-08 (Crawled : 13:15) - prnewswire.com
SYK | $325.43 -0.62% 0.0% 1.8M
|
Health Technology
|
| O: -0.15%
H: 0.61%
C: -0.71%
IVC | $0.6598 -19.67% 0
|
Health Technology
|
| O: 0.0%
H: 6.41%
C: 5.72%
EKSO | $1.35 11.57% 10.37% 52K
|
Health Technology
|
| O: 0.69%
H: 0.92%
C: -1.61%
therapy growing iot
Turning Point Therapeutics Granted Breakthrough Therapy Designation for Repotrectinib Treatment in Patients with NTRK-Positive, TKI-Pretreated Advanced Solid Tumors
Published: 2021-10-04 (Crawled : 13:15) - globenewswire.com
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: -0.53%
H: 2.39%
C: -0.01%
treatment solid tumors positive therapy breakthrough therapy granted grant designation
UPDATE: Sio Gene Therapies to Present New Data at the European Society of Gene and Cell Therapy Virtual Congress 2021
Published: 2021-10-04 (Crawled : 13:15) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 5.58%
H: 6.02%
C: 0.88%
europe gene therapies therapy gene therapy
Zai Lab Partner Turning Point Therapeutics Granted Breakthrough Therapy Designation for Repotrectinib Treatment in Patients With NTRK-Positive, TKI-Pretreated Advanced Solid Tumors
Published: 2021-10-04 (Crawled : 13:15) - globenewswire.com
ZLAB | $14.08 -0.99% -0.99% 470K
|
Health Technology
|
| O: -4.58%
H: 2.65%
C: 0.49%
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: -0.53%
H: 2.39%
C: -0.01%
treatment solid tumors positive therapy breakthrough therapy granted designation
Autologous Cell Therapy Market analysis in Pharmaceuticals Industry | $ 4.11 Bn growth expected during 2021-2025 | 17,000+ Technavio Research Reports
Published: 2021-09-20 (Crawled : 13:15) - prnewswire.com
BCLI A | $0.5384 4.69% 4.48% 1M
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: -2.58%
therapy growth research
Oncolytics Biotech® Announces Preclinical Data Demonstrating the Synergistic Immunotherapeutic Effects of Pelareorep Combined with Radiotherapy
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.52%
H: 9.63%
C: 3.06%
therapy biotech iot preclinical pre-clinical
Oncternal Therapeutics and Celularity Enter into Research Collaboration to Evaluate Targeted Placental-Derived Cellular Therapies
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
CELU | News F | $3.09 -3.74% -3.88% 24K
|
|
| O: 0.0%
H: 1.76%
C: 0.8%
ONCT | $8.97 4.3% 4.12% 4.5K
|
Health Technology
|
| O: -5.66%
H: 2.5%
C: -1.75%
collaboration research therapy
Celularity and Oncternal Therapeutics Enter into Research Collaboration to Evaluate Targeted Placental-Derived Cellular Therapies
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
CELU | News F | $3.09 -3.74% -3.88% 24K
|
|
| O: 0.0%
H: 1.76%
C: 0.8%
ONCT | $8.97 4.3% 4.12% 4.5K
|
Health Technology
|
| O: -5.66%
H: 2.5%
C: -1.75%
collaboration research therapy
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) + Chemotherapy for Patients with HER2-Negative Advanced or Metastatic Gastric, Gastroesophageal Junction
Published: 2021-09-17 (Crawled : 13:15) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -1.14%
H: 0.0%
C: 0.0%
positive therapy chmp her2+ her2- her2 nivolumab
CG Oncology Announces Clinical Trial Collaboration with Bristol Myers Squibb to Evaluate Oncolytic Immunotherapy CG0070 in Combination with OPDIVO® (nivolumab) in Metastatic Urothelial Cancer
Published: 2021-09-09 (Crawled : 13:15) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.74%
H: 0.49%
C: -1.33%
immunotherapy therapy collaboration cancer trial nivolumab
Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies
Published: 2021-08-20 (Crawled : 13:15) - globenewswire.com
CCEL | $7.61 3.26% -1.44% 23K
|
Manufacturing
| Email alert
Add to watchlist
cryo acquisition therapy
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.